New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - methotrexate 100 mg/ml - concentrate for injection - 100 mg/ml - active: methotrexate 100 mg/ml excipient: sodium hydroxide water for injection - antineoplastic chemotherapy. methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer and the palliation of acute and subacute lymphocytic leukaemia (greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias). methotrexate is now most commonly used for the maintenance of medicine induced remissions. high dose therapy. in high dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic carcinoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy. psoriasis chemotherapy. methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatological consultation.

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 100 mg/ml;   - solution for injection - 100 mg/ml - active: methotrexate 100 mg/ml   excipient: hydrochloric acid sodium hydroxide water for injection

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - methotrexate 100 mg/ml - concentrate for solution for infusion - 100 mg/ml - methotrexate 100 mg/ml - methotrexate

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - methotrexate 100 mg/ml - concentrate for solution for infusion - 100 mg/ml - methotrexate 100 mg/ml - methotrexate

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - methotrexate 100 mg/ml - concentrate for solution for infusion - 100 mg/ml - methotrexate 100 mg/ml - methotrexate

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - methotrexate 100 mg/ml - concentrate for solution for infusion - 100 mg/ml - methotrexate 100 mg/ml - methotrexate

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - methotrexate 100 mg/ml - concentrate for solution for infusion - 100 mg/ml - methotrexate 100 mg/ml - methotrexate